Cargando…

Quality and acceptability of patient-reported outcome measures used to assess fatigue in axial spondyloarthritis (axSpA): a systematic review (protocol)

BACKGROUND: The prevalence of axial spondyloarthritis (axSpA) is estimated between 0.15 and 1.2%, with many of those patients experiencing severe fatigue. Current axSpA assessment guidance recommends use of a single-item visual analogue scale for fatigue severity. However, concerns have been raised...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pearson, Nathan A., Packham, Jonathan C., Parsons, Helen, Haywood, Kirstie L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081943/ https://www.ncbi.nlm.nih.gov/pubmed/30086791 http://dx.doi.org/10.1186/s13643-018-0777-7

Ejemplares similares

Assessing fatigue in adults with axial spondyloarthritis: a systematic review of the quality and acceptability of patient-reported outcome measures
por: Pearson, Nathan A, et al.
Publicado: (2018)

Non-Radiographic Axial Spondyloarthritis (nr-axSpA): Advances in Classification, Imaging and Therapy
por: Robinson, Philip C., et al.
Publicado: (2019)

Sera of patients with axial spondyloarthritis (axSpA) enhance osteoclastogenic potential of monocytes isolated from healthy individuals
por: Korkosz, Mariusz, et al.
Publicado: (2018)

Sustained low functional impairment in axial spondyloarthritis (axSpA): which are the primary outcomes that should be targeted to achieve this?
por: Maksymowych, Walter P., et al.
Publicado: (2023)

Predicting response to anti-TNFα therapy among patients with axial spondyloarthritis (axSpA): results from BSRBR-AS
por: Macfarlane, Gary J, et al.
Publicado: (2020)

Association of anxiety, depression and resilience with overall health and functioning in axial spondyloarthritis (axSpA): a cross-sectional study
por: Chung, Deborah Xin Yi, et al.
Publicado: (2023)

Sustained efficacy, safety and patient-reported outcomes of certolizumab pegol in axial spondyloarthritis: 4-year outcomes from RAPID-axSpA
por: van der Heijde, Désirée, et al.
Publicado: (2017)

Qualitative interview study exploring the patient experience of living with axial spondyloarthritis and fatigue: difficult, demanding and draining
por: Pearson, Nathan Ashley, et al.
Publicado: (2022)

Development of the Warwick Axial Spondyloarthritis faTigue and Energy questionnaire (WASTEd)—a new patient-reported outcome measure
por: Pearson, Nathan A, et al.
Publicado: (2022)

Comparison of patients with axial PsA and patients with axSpA and concomitant psoriasis: an analysis of the German register RABBIT-SpA
por: Regierer, Anne Constanze, et al.
Publicado: (2023)

Non-radiographic versus radiographic axSpA: what’s in a name?
por: Michelena, Xabier, et al.
Publicado: (2020)

Limited radiographic progression and sustained reductions in MRI inflammation in patients with axial spondyloarthritis: 4-year imaging outcomes from the RAPID-axSpA phase III randomised trial
por: van der Heijde, Désirée, et al.
Publicado: (2018)

Multi-b-values-fitting readout-segmentation of long variable echo-trains diffusion-weighted imaging (RESOLVE DWI) in evaluation of disease activity and curative effect of axial spondyloarthritis (axSpA)
por: Chen, Xianyuan, et al.
Publicado: (2023)

How Has Molecular Biology Enhanced Our Undertaking of axSpA and Its Management
por: Fatica, Mauro, et al.
Publicado: (2022)

Quantifying and predicting the effect of anti-TNF therapy on axSpA-related fatigue: results from the BSRBR-AS registry and meta-analysis
por: Shim, Joanna, et al.
Publicado: (2020)

Beantwortung epidemiologisch-rheumatologischer Fragestellungen durch Kooperation mit der bevölkerungsbasierten SHIP-Kohorte – Erkenntnisse für die Diagnostik der axialen Spondyloarthritis (axSpA)
por: Braun, J., et al.
Publicado: (2021)

Depressive symptoms are associated with fatigue, poorer functional status and less engagement in sports in axSpA and PsA: an analysis from the RABBIT-SpA cohort
por: Reich, Andreas, et al.
Publicado: (2023)

AxSpA patients who also meet criteria for fibromyalgia: identifying distinct patient clusters using data from a UK national register (BSRBR-AS)
por: Macfarlane, Gary J., et al.
Publicado: (2019)

Effectiveness of Shiatsu on Fatigue in Patients with Axial Spondyloarthritis: Protocol for a Randomized Cross-Over Pilot Study
por: Bernardinelli, Nathalie, et al.
Publicado: (2023)

Structural Lesion Progression of the Sacroiliac Joint and Clinical Features in axSpA During TNFi Reduction: A Retrospective Cohort Study
por: Mo, Qian, et al.
Publicado: (2021)

Facet joint ankylosis in r-axSpA: detection and 2-year progression on whole spine low-dose CT and comparison with syndesmophyte progression
por: Stal, Rosalinde, et al.
Publicado: (2020)

Optimizing outcomes for ankylosing spondylitis and axial spondyloarthritis patients: a holistic approach to care
por: Packham, Jonathan
Publicado: (2018)

Web-based physiotherapy for people with axial spondyloarthritis (WEBPASS) – a study protocol
por: Paul, L., et al.
Publicado: (2016)

Traditional Chinese medicine (TCM) collaborative care for patients with axial spondyloarthritis (AcuSpA): protocol for a pragmatic randomized controlled trial
por: Kwan, Yu Heng, et al.
Publicado: (2019)

Diagnostic delay in axial spondyloarthritis: a systematic review
por: Hay, Charles A., et al.
Publicado: (2022)

Objective Measurements of Physical Activity and Sedentary Behavior Using Wearable Devices in Patients With Axial Spondyloarthritis: Protocol for a Systematic Review
por: Carlin, Thomas, et al.
Publicado: (2021)

Feasibility, acceptability and change in health following a telephone-based cognitive behaviour therapy intervention for patients with axial spondyloarthritis
por: Pedley, Rebecca, et al.
Publicado: (2020)

Certolizumab Pegol Efficacy in Patients With Non‐Radiographic Axial Spondyloarthritis Stratified by Baseline MRI and C‐Reactive Protein Status: An Analysis From the C‐axSpAnd Study
por: Robinson, Philip C., et al.
Publicado: (2022)

The prevalence of fibromyalgia in axial spondyloarthritis
por: Jones, Gareth T., et al.
Publicado: (2020)

Influence of co-morbid fibromyalgia on disease activity measures and response to tumour necrosis factor inhibitors in axial spondyloarthritis: results from a UK national register
por: Macfarlane, Gary J, et al.
Publicado: (2018)

Etanercept in axial spondyloarthritis
por: Luo, Gui, et al.
Publicado: (2022)

Exploring the Prevalence and Factors Associated With Fatigue in Axial Spondyloarthritis in an Asian Cohort in Singapore
por: Lim, Wei Ze, et al.
Publicado: (2021)

An international collaborative study to co-produce a patient-reported outcome measure of cardiac arrest survivorship and health-related quality of life (CASHQoL): A protocol for developing the long-form measure
por: Haywood, Kirstie L., et al.
Publicado: (2022)

The Nonradiographic Axial Spondyloarthritis, the Radiographic Axial Spondyloarthritis, and Ankylosing Spondylitis: The Tangled Skein of Rheumatology
por: Malaviya, Anand N., et al.
Publicado: (2017)

Long-term safety and clinical outcomes of certolizumab pegol treatment in patients with active non-radiographic axial spondyloarthritis: 3-year results from the phase 3 C-axSpAnd study
por: van der Heijde, Désirée, et al.
Publicado: (2022)

Cytokine profiles in axial spondyloarthritis
por: Madej, Marta, et al.
Publicado: (2015)

Patient Burden of Axial Spondyloarthritis
por: Strand, Vibeke, et al.
Publicado: (2017)

Axial Spondyloarthritis and Cigarette Smoking
por: Kaut, Irène Kona, et al.
Publicado: (2017)

Axial spondyloarthritis: coming of age
por: Marzo-Ortega, Helena
Publicado: (2020)

Genetics and the axial spondyloarthritis spectrum
por: Brown, Matthew A, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2tmetotn0dholm9unbit14fvr1